Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Valsartan Market Price & Analysis > Market Insights - Valsartan > Ruibo (Suzhou) Pharmaceutical Sacubitril and Valsartan Sodium API and intermediates passed the Japanese GMP review
— Share —

Ruibo (Suzhou) Pharmaceutical Sacubitril and Valsartan Sodium API and intermediates passed the Japanese GMP review

healthoo 2021-10-19
Recently, Ruibo (Suzhou) Pharmaceutical Co., Ltd. (hereinafter referred to as “Ruibo Suzhou”), a wholly-owned subsidiary of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.